Kezar Life Sciences, Inc. Quarterly Depreciation in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kezar Life Sciences, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q3 2024.
  • Kezar Life Sciences, Inc. Depreciation for the quarter ending September 30, 2024 was $300K, unchanged year-over-year.
  • Kezar Life Sciences, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.2M, a 20% increase year-over-year.
  • Kezar Life Sciences, Inc. annual Depreciation for 2023 was $1.1M, a 10% increase from 2022.
  • Kezar Life Sciences, Inc. annual Depreciation for 2022 was $1M, a 11.1% increase from 2021.
  • Kezar Life Sciences, Inc. annual Depreciation for 2021 was $900K, unchanged from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.2M $300K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.2M $300K +$100K +50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.1M $300K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.1M $300K +$100K +50% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $1M $300K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1M $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1M $300K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1M $200K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1M $300K +$100K +50% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $900K $200K -$100K -33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1M $300K +$100K +50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $900K $200K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $900K $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $900K $300K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $900K $200K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $900K $200K -$100K -33.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 $1M $200K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1M $300K +$100K +50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $900K $200K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $900K $300K +$100K +50% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $800K $200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $800K $200K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $800K $200K +$100K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $700K $200K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 $200K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $200K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $100K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.